Catherine Wood's GH Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 691,647 shares of Guardant Health, Inc. (GH) worth $70.64 M, representing 0.47% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in GH, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 1.41 M shares. Largest reduction occurred in Q3 2025, reducing 2.03 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Guardant Health (GH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Guardant Health (GH) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -103,587 | Reduce 13.03% | 691,647 | $102.14 |
| Q3 2025 | -2.03 M | Reduce 71.84% | 795,234 | $62.48 |
| Q2 2025 | +1.41 M | Add 100.37% | 2.82 M | $52.04 |
| Q1 2025 | -30,736 | Reduce 2.13% | 1.41 M | $42.60 |
| Q4 2024 | -72,842 | Reduce 4.82% | 1.44 M | $30.55 |
| Q3 2024 | +1.06 M | Add 233.49% | 1.51 M | $22.94 |
| Q2 2024 | +92,424 | Add 25.59% | 453,590 | $28.88 |
| Q1 2024 | -76,934 | Reduce 17.56% | 361,166 | $20.63 |
| Q4 2023 | -135,223 | Reduce 23.59% | 438,100 | $27.05 |
| Q3 2023 | -1,672 | Reduce 0.29% | 573,323 | $29.64 |
| Q2 2023 | -8,260 | Reduce 1.42% | 574,995 | $35.80 |
| Q1 2023 | +83,149 | Add 16.63% | 583,255 | $23.44 |
| Q4 2022 | -42,007 | Reduce 7.75% | 500,106 | $27.20 |
| Q3 2022 | +542,113 | New Buy | 542,113 | $53.83 |
| Q1 2022 | -82 | Sold Out | 0 | $0.00 |
| Q4 2021 | -11 | Reduce 11.83% | 82 | $97.56 |
| Q2 2021 | -703,157 | Reduce 99.99% | 93 | $129.03 |
| Q1 2021 | +162,713 | Add 30.10% | 703,250 | $152.65 |
| Q4 2020 | +306,516 | Add 130.98% | 540,537 | $128.88 |
| Q3 2020 | -224,531 | Reduce 48.97% | 234,021 | $111.78 |
| Q2 2020 | +210,901 | Add 85.16% | 458,552 | $81.13 |
| Q1 2020 | +95,844 | Add 63.14% | 247,651 | $69.60 |
| Q4 2019 | +77,604 | Add 104.58% | 151,807 | $78.14 |
| Q3 2019 | +162 | Add 0.22% | 74,203 | $63.82 |
| Q2 2019 | +74,041 | New Buy | 74,041 | $86.33 |
Catherine Wood's Guardant Health Investment FAQs
Catherine Wood first purchased Guardant Health, Inc. (GH) in Q2 2019, acquiring 74,041 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Guardant Health, Inc. (GH) for 26 quarters since Q2 2019.
Catherine Wood's largest addition to Guardant Health, Inc. (GH) was in Q2 2025, adding 2,823,497 shares worth $146.93 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 691,647 shares of Guardant Health, Inc. (GH), valued at approximately $70.64 M.
As of the Q4 2025 filing, Guardant Health, Inc. (GH) represents approximately 0.47% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Guardant Health, Inc. (GH) was 2,823,497 shares, as reported at the end of Q2 2025.